Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
1.
Br J Cancer ; 108(7): 1408-14, 2013 Apr 16.
Artigo em Inglês | MEDLINE | ID: mdl-23511562

RESUMO

BACKGROUND: There exists evidence that body mass index (BMI) impacts on the efficacy of aromatase inhibitors in patients with breast cancer. The relationship between BMI and the efficacy of tamoxifen is conflicting. We investigated the impact of BMI on the efficacy of single tamoxifen and tamoxifen plus an aromatase inhibitor in the well-defined prospective study population of the ABCSG-06 trial. METHODS: ABCSG-06 investigated the efficacy of tamoxifen vs tamoxifen plus aminoglutethimide in postmenopausal women with hormone receptor-positive breast cancer. Taking BMI at baseline, patients were classified as normal weight (BMI=18.5-24.9 kg m(-)(2)), overweight (BMI=25-29.9 kg m(-)(2)), and obese (30 kg m(-)(2)) according to WHO criteria. RESULTS: Overweight+obese patients had an increased risk for distant recurrences (hazard ratio (HR): 1.51; Cox P=0·018) and a worse overall survival (OS; HR: 1·49; Cox P=0·052) compared with normal weight patients. Analysing patients treated with single tamoxifen only, no difference between overweight+obese patients and normal weight patients regarding distant recurrence-free survival (HR: 1.35; Cox P=0·24) and OS (HR: 0.99; Cox P=0·97) could be observed. In contrast, in the group of patients treated with the combination of tamoxifen plus aminoglutethimide, overweight+obese patients had an increased risk for distant recurrences (1.67; Cox P=0·03) and a worse OS (1.47; Cox P=0·11) compared with normal weight patients. CONCLUSION: BMI impacts on the efficacy of aromatase inhibitor-based treatment but not single tamoxifen.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Sobrepeso/fisiopatologia , Tamoxifeno/uso terapêutico , Idoso , Idoso de 80 Anos ou mais , Aminoglutetimida/administração & dosagem , Aminoglutetimida/efeitos adversos , Antineoplásicos Hormonais/administração & dosagem , Antineoplásicos Hormonais/efeitos adversos , Antineoplásicos Hormonais/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Inibidores da Aromatase/administração & dosagem , Inibidores da Aromatase/efeitos adversos , Índice de Massa Corporal , Neoplasias da Mama/metabolismo , Neoplasias da Mama/fisiopatologia , Feminino , Humanos , Pessoa de Meia-Idade , Pós-Menopausa , Estudos Prospectivos , Receptores de Superfície Celular/biossíntese , Tamoxifeno/administração & dosagem , Tamoxifeno/efeitos adversos , Resultado do Tratamento
2.
J Clin Oncol ; 12(5): 970-4, 1994 May.
Artigo em Inglês | MEDLINE | ID: mdl-8164049

RESUMO

PURPOSE: The long-term survival probability of patients who undergo surgery for stage 3 and 4 gastric cancer is poor, predominantly due to metastatic spread of the tumor. Depending on the type of tumor histology, the pathway of metastases is mainly peritoneal or hepatic dissemination. Interruption of this mechanism may be possible by intraperitoneal chemotherapy (IPT). PATIENTS AND METHODS: In a prospective randomized trial of 67 patients undergoing surgery for stage 3 and 4 gastric cancer, 33 patients underwent adjuvant postoperative IPT with cisplatin, while 34 control subjects remained untreated. RESULTS: Patients in the treatment group received a median of four IPT perfusions. Apart from frequent nausea, no adverse reactions or complications were noted. The median disease-free survival durations were 12.7 months and 9.7 months in treated patients and controls, respectively (P = .8). After a median follow-up duration of 72 months, 54 patients (80%) had died of primary disease or related complications. The median survival duration for IPT patients was 17.3 months as compared with 16.0 months for controls (P = .6). Autopsies were performed on 12 (18%) of 54 patients who died, and showed tumor spread to the peritoneal cavity and/or to the liver, irrespective of the application of IPT. CONCLUSION: IPT with cisplatin monotherapy does not improve survival probability after surgery for stage 3 and 4 gastric cancer. The reasons for ineffectiveness of IPT may be the choice of an unsuitable chemotherapeutic agent, an inefficient modus of application, or a lack of sufficient drug penetration into the serosa or peritoneal metastasis.


Assuntos
Cisplatino/uso terapêutico , Neoplasias Peritoneais/secundário , Neoplasias Gástricas/tratamento farmacológico , Neoplasias Gástricas/cirurgia , Idoso , Quimioterapia Adjuvante , Cisplatino/administração & dosagem , Humanos , Infusões Parenterais , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Neoplasias Peritoneais/prevenção & controle , Modelos de Riscos Proporcionais , Estudos Prospectivos , Neoplasias Gástricas/mortalidade , Neoplasias Gástricas/patologia , Análise de Sobrevida
3.
Neoplasma ; 39(3): 185-8, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1528324

RESUMO

Reduction of mortality rates and the costs of screening programs have sometimes been discussed on basis of certain therapeutic nihilism especially concerning the treatment of some cancer localizations. Interest of an epidemiological institute should, however, concern specific regions with high cancer risk and in these areas, well defined by epidemiological investigations, screening projects should be performed. A screening program initiated in Oberpullendorf, a district in the federal country of Burgenland in Austria resulted in a rate of 53% Dukes A colorectal cancer stages (0% Dukes D) compared to 27% Dukes A stage (19% Dukes D) without screening. As regards the lung cancer screening programs, these are controversial, due to high costs and no evident influence on mortality rates. The mortality rate for Vienna is about 20% above the Austrian average. In women the discrepancy between the capital and the federal countries is especially high, as in Vienna 44% more women die on lung cancer as compared to the Austrian average. Some promising results in the treatment of lung cancer, especially in small cell carcinoma and combined treatment by chemo- and radiotherapy might justify a screening program for lung cancer. The highest increase of mortality in lung cancer is found in patients at the age of 75 and older. Those patients, however, suffer from other diseases too, therefore "screening programs for polymorbidity" should be discussed.


Assuntos
Neoplasias Colorretais/epidemiologia , Programas de Rastreamento/métodos , Adulto , Áustria/epidemiologia , Neoplasias Colorretais/diagnóstico , Neoplasias Colorretais/prevenção & controle , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias
4.
Wien Klin Wochenschr ; 103(10): 288-95, 1991.
Artigo em Alemão | MEDLINE | ID: mdl-1858377

RESUMO

In 1987/88 and 1988/89 we tested the population (aged greater than or equal to 40) of the district of Oberpullendorf in 2 series for faecal occult blood by means of the Hemdetect Test. In the first test series the test was offered to 18,233 persons and 8235 (45%) persons completed the test; 187 (2.3%) were positive. In the second series 6512 (36%) out of 18,241 completed the test and 472 (7.2%) persons were positive. The persons with positive results were examined by colonoscopy, gastroscopy, and abdominal sonography, in combination with routine investigations. Secondary compliance in these investigations was 92%. The screening method revealed 34 colorectal cancers with the favourable pathological staging: Dukes A 18 (53%), Dukes B 6 (18%), Dukes C 10 (29%), Dukes D 0. 11 polyps showing carcinoma in situ and 174 polyps (70% of which were adenomas) in 124 patients were treated by colonoscopy. In the meantime we have detected 14 "interval" cancers among people with a false negative test result, also at a favourable staging: Dukes A 6 (43%), Dukes B 4 (29%), Dukes C 4 (29%), Dukes D 0. In the non-responders we found 30 colorectal cancers at a much worse staging: Dukes A 7 (23%), Dukes B 10 (33%), Dukes C 8 (27%), and Dukes D 5 (17%). Screening for faecal occult blood in combination with the necessary investigations of the positive persons by colonoscopy is able to detect symptomless colorectal cancers at a less advanced pathological stage and enables the treatment of precancerous adenomatous polyps. An improvement in cumulative sensitivity is expected on annual repetition of screening for faecal occult blood.


Assuntos
Neoplasias Colorretais/epidemiologia , Programas de Rastreamento , Sangue Oculto , Adulto , Idoso , Áustria/epidemiologia , Colonoscopia , Neoplasias Colorretais/diagnóstico , Feminino , Gastroscopia , Humanos , Masculino , Pessoa de Meia-Idade , Vigilância da População , Sensibilidade e Especificidade
5.
Wien Klin Wochenschr ; 92(6): 191-4, 1980 Mar 14.
Artigo em Alemão | MEDLINE | ID: mdl-7395232

RESUMO

Spontaneous mesenteric venous thrombosis without recognizable aetiology is a rare condition. Only 10 cases have been described in world literature as a complication of oral contraceptives. The case report is presented of a 51 year-old married woman who had been taking oral contraceptives for 7 years. After abdominal pain for weeks segmental mesenteric venous thrombosis with a gangrenous small bowel loop was diagnosed. The gangrenous small bowel loop was treated by resection. Subsequently after discontinuance of contraceptive medication she was symptom free. The problems of diagnosis are pointed out and it is suggested that immediate discontinuance of oral contraceptives in women with unexplained abdominal pain might prevent gangrene of small bowel.


PIP: A 51-year-old woman who had used the oral contraceptive Lyndiol for 7 years developed severe abdominal pains that lasted for several weeks. There were no unequivocal clinical, laboratory test, or X-ray results to determine the cause of the pains. The patient was operated on for resection of a gangrenous loop of the small intestine, caused by a mesenteric venous thrombosis. It is possible that discontinuation of oral contraceptive use may have prevented the gangrene. Discontinuation of oral contraceptive use is recommended for women with unexplained abdominal pains.


Assuntos
Anticoncepcionais Orais Hormonais/efeitos adversos , Anticoncepcionais Orais/efeitos adversos , Oclusão Vascular Mesentérica/induzido quimicamente , Trombose/induzido quimicamente , Feminino , Gangrena/etiologia , Humanos , Intestino Delgado/cirurgia , Veias Mesentéricas , Pessoa de Meia-Idade
6.
Wien Klin Wochenschr ; 91(8): 265-6, 1979 Apr 13.
Artigo em Alemão | MEDLINE | ID: mdl-452609

RESUMO

Factor XIII concentration was investigated pre- and postoperatively in the plasma of 139 patients undergoing major abdominal surgery. Postoperative complications (impairment of wound healing and haemorrhage) were significantly more frequently seen in patients with a low concentration of factor XIII. A low preoperative concentration of factor XIII can be interpreted as a high risk factor.


Assuntos
Fator XIII/análise , Hemorragia/sangue , Complicações Pós-Operatórias/sangue , Cicatrização , Feminino , Humanos , Masculino , Risco
7.
Wien Klin Wochenschr ; 96(4): 144-9, 1984 Feb 17.
Artigo em Alemão | MEDLINE | ID: mdl-6608833

RESUMO

Highly selective vagotomy was performed in 361 patients over the past 10 years. The mortality was 0.3% in uncomplicated, and 1.6% in complicated duodenal ulcer. With a mean follow-up period of 52 months the recurrence rate was 7.4%. The known advantages of this operation, namely low mortality and low postoperative morbidity (dumping 0.8%, diarrhoea 0.8%, unintentional weight loss 0%, food intolerance 1.9% and epigastric fullness after meals 1.9%), were confirmed in our patients. The overall clinical result was excellent or good (Visick I or II) in 87% of patients. Clinical failures were most often caused by recurrent ulceration. Highly selective vagotomy is still the operation of choice in uncomplicated duodenal ulcer. It can also be recommended in selected cases of complicated ulcer disease.


Assuntos
Úlcera Duodenal/cirurgia , Vagotomia Gástrica Proximal , Vagotomia , Adulto , Idoso , Esvaziamento Gástrico , Hemorragia Gastrointestinal/etiologia , Humanos , Pessoa de Meia-Idade , Complicações Pós-Operatórias , Recidiva
8.
Wien Klin Wochenschr ; 99(12): 415-20, 1987 Jun 12.
Artigo em Alemão | MEDLINE | ID: mdl-3617769

RESUMO

The peritoneum is a frequent location of recurrent disease after surgical treatment of carcinoma of the stomach, colon, rectum or ovary. Usually this type of recurrence does not respond very well to systemic chemotherapy. The rational of intraperitoneal (ip) perfusion with cytotoxic drugs is based on a 2- to 3-log-fold increase in ip level over plasma concentration for certain chemotherapeutic agents. Hence, malignant cells in the peritoneal cavity can be exposed to very high concentrations of cytotoxic agents without serious systemic side effects. Remission rates of peritoneal carcinoma after ip perfusion of a range of chemotherapeutic substances varied from between 15 to 50%. Minimal information is available about adjuvant ip perfusion after operation for cure. Toxicity data are presented from our adjuvant trial using ip perfusion after operation for gastric carcinoma for cure with cisplatin in a randomized fashion. Altogether 59 perfusions were performed, with minimal systemic toxicity, no occurrence of peritonitis and only 1 portal infection. Immunological data show that 1 day after ip perfusion the concentration of natural killer cells is increased in 60% of all perfusions, but decreased only in 28%. We conclude that ip perfusion with cisplatin is a safe procedure with limited toxicity. The efficacy of this technique in peritoneal carcinosis is not yet proven in randomized trials. The observation period of our trial in the adjuvant stage after operation for gastric carcinoma is too short as get to assess the usefulness of the procedure.


Assuntos
Antineoplásicos/efeitos adversos , Quimioterapia do Câncer por Perfusão Regional , Neoplasias Peritoneais/secundário , Neoplasias Gástricas/tratamento farmacológico , Antineoplásicos/administração & dosagem , Cisplatino/efeitos adversos , Terapia Combinada , Humanos , Neoplasias Peritoneais/tratamento farmacológico , Neoplasias Gástricas/cirurgia
9.
Wien Klin Wochenschr ; 98(24): 824-30, 1986 Dec 19.
Artigo em Alemão | MEDLINE | ID: mdl-3103336

RESUMO

102 patients with operable gastric carcinoma were randomly allocated to untreated control, polychemotherapy, chemoimmunotherapy. At a median follow-up of 5 years, chemotherapy did not improve the overall survival rate. However, in certain subgroups, patients with lymphnode metastases and intestinal tumor type showed a significant survival benefit when treated with adjuvant chemotherapy. Furthermore, we found the site of first recurrence very closely related to the type of tumor histology. Regardless of the positive effect of chemotherapy in retrospective subset-analysis, we do not generally recommend the use of polychemotherapy in operable gastric carcinoma.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Gastrectomia , Neoplasias Gástricas/tratamento farmacológico , Idoso , Terapia Combinada , Citarabina/administração & dosagem , Fluoruracila/administração & dosagem , Seguimentos , Humanos , Mitomicina , Mitomicinas/administração & dosagem , Estadiamento de Neoplasias , Estudos Prospectivos , Distribuição Aleatória , Neoplasias Gástricas/patologia , Neoplasias Gástricas/cirurgia
12.
Phys Rev Lett ; 103(8): 087405, 2009 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-19792763

RESUMO

We present a combined experimental and theoretical study of the emission spectrum of zero dimensional nanocavity polaritons in electrically tunable single dot nanocavities. Such devices allow us to vary the dot-cavity detuning in situ and probe the emission spectrum under well-controlled conditions of lattice temperature and incoherent excitation level. Our results show that the observation of a double peak in the emission spectrum is not an unequivocal signature of strong coupling. Moreover, by comparing our results with theory, we extract the effective vacuum Rabi splitting, the pure dephasing rate, and their dependence on the incoherent optical pumping power and lattice temperature. Our study highlights how coupling to the lattice and dynamical fluctuations in the solid-state environment influence the coherence properties of quantum dot microcavity polaritons and, sometimes, may mask the occurrence of strong coupling.

13.
Br J Cancer ; 97(8): 1021-7, 2007 Oct 22.
Artigo em Inglês | MEDLINE | ID: mdl-17895886

RESUMO

The purpose of this trial was to investigate the efficacy of adjuvant chemotherapy with 5-fluorouracil (5-FU) and leucovorin (LV) in stage II colon cancer. Patients with stage II colon cancer were randomised to either adjuvant chemotherapy with 5-FU/LV (100 mg m(-2) LV+450 mg m(-2) 5-FU weekly, weeks 1-6, in 8 weeks cycles x 7) or surveillance only. Five hundred patients were evaluable for analyses. After a median follow-up of 95.6 months, 55 of 252 patients (21.8%) have died in the 5-FU/LV arm and 58 of 248 patients (23.4%) in the surveillance arm. There was no statistically significant difference in overall survival (OS) between the two treatment arms (hazard ratios, HR 0.88, 95% CI 0.61-1.27, P=0.49). The relative risk for tumour relapse was higher for patients on the surveillance arm than for those on the 5-FU/LV arm; however, this difference was not statistically significant (HR 0.69, 95% CI 0.45-1.06, P=0.09). Consequently, disease-free survival (DFS) was not significantly different between the two trial arms. In conclusion, results of this trial demonstrate a trend to a lower risk for relapse in patients treated with adjuvant 5-FU/LV for stage II colon cancer. However, in this study with limited power to detect small differences between the study arms, adjuvant chemotherapy failed to significantly improve DFS and OS.


Assuntos
Adenocarcinoma/tratamento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias do Colo/tratamento farmacológico , Recidiva Local de Neoplasia/prevenção & controle , Adenocarcinoma/mortalidade , Adenocarcinoma/patologia , Adulto , Idoso , Quimioterapia Adjuvante , Neoplasias do Colo/mortalidade , Neoplasias do Colo/patologia , Intervalo Livre de Doença , Feminino , Fluoruracila/administração & dosagem , Humanos , Estimativa de Kaplan-Meier , Leucovorina/administração & dosagem , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias
14.
Br J Cancer ; 92(9): 1655-62, 2005 May 09.
Artigo em Inglês | MEDLINE | ID: mdl-15856042

RESUMO

The purpose of this trial was to examine the efficacy of the addition of levamisole (LEV) or interferon alfa (IFN) to an adjuvant chemotherapy with 5-fluorouracil (5-FU) in patients with stage III colon cancer. According to a 2 x 2 factorial study design, 598 patients were randomly assigned to one of four adjuvant treatment arms. Patients in arm one received 5-FU weekly for 1 year, patients in arm two 5-FU plus LEV, in arm three 5-FU plus IFN and patients in arm four 5-FU, LEV and IFN. The relative risk of relapse and the relative risk of death were significantly higher for patients treated with LEV compared with those without LEV treatment (HR 1.452, 95% CI 1.135-1.856, P=0.0028; HR 1.506, 95% CI 1.150-1.973, P=0.0027, respectively). No significant impact on survival was observed for therapy with IFN in the univariate analysis. The addition of LEV to adjuvant 5-FU significantly worsened the prognosis of patients with stage III colon cancer. Interferon alfa had no significant influence on survival when combined with adjuvant 5-FU, but increased the toxicity of therapy substantially.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias do Colo/tratamento farmacológico , Neoplasias do Colo/cirurgia , Terapia Combinada , Intervalo Livre de Doença , Esquema de Medicação , Feminino , Fluoruracila/administração & dosagem , Humanos , Interferon-alfa/administração & dosagem , Interferon-alfa/efeitos adversos , Leucovorina/administração & dosagem , Levamisol/administração & dosagem , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia , Prognóstico , Análise de Sobrevida
15.
MMW Munch Med Wochenschr ; 122(43): 1495-8, 1980 Oct 24.
Artigo em Alemão | MEDLINE | ID: mdl-6780841

RESUMO

The aim of the study was to compare the effect of three possibilities of prophylaxis of thromboembolism: low dose heparin, acetylsalicylic acid (ASA) and a combination of the two. The evaluation of the clinical observations showed no significant differences between the three prophylaxis groups. The iodine fibrinogen test showed no different reaction with regard to the leg, a superiority of ASA in the thigh was suggested, at least in our random samples. Whether this observation is the reason why the frequency of fatal pulmonary emboli can be reduced by ASA is discussed. The complete calculation points to a superiority for ASA here. The size of the selected samples is, however, too small for more definite statements.


Assuntos
Aspirina/uso terapêutico , Heparina/uso terapêutico , Complicações Pós-Operatórias/prevenção & controle , Tromboembolia/prevenção & controle , Abdome/cirurgia , Adulto , Relação Dose-Resposta a Droga , Método Duplo-Cego , Quimioterapia Combinada , Feminino , Humanos , Pessoa de Meia-Idade
16.
MMW Munch Med Wochenschr ; 117(18): 763-6, 1975 May 02.
Artigo em Alemão | MEDLINE | ID: mdl-805939

RESUMO

Period I (1958-64)included 227 complications, period II 257 complications. Altogether, 484 complications were evaluated in 436 cases. The by far higher lethality in period I (71,3 percent) compared to 41,1 per cent in period II can be explained by the lower frequency of relaparotomy of 24,6 percent (52,3 per cent in period II). The mortality after relaparotomy was almost equal in both periods. The central problem in the therapy of postoperative surgical complications can consequently be seen in the indications for relaparotomy. Therefore, to improve the results, a more active diagnosis and indication and adequate performance of the operation are necessary.


Assuntos
Abdome/cirurgia , Complicações Pós-Operatórias/terapia , Erros de Diagnóstico , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/etiologia , Humanos , Obstrução Intestinal/etiologia , Peritonite/diagnóstico , Peritonite/etiologia , Peritonite/mortalidade , Peritonite/cirurgia , Complicações Pós-Operatórias/prevenção & controle , Deiscência da Ferida Operatória
17.
Arch Orthop Unfallchir ; 84(2): 235-47, 1976 Mar 26.
Artigo em Alemão | MEDLINE | ID: mdl-1267682

RESUMO

140 fractures of the olecranon were treated (69 conservatively, 71 surgically), of whom 71 were followed up (28 conservative, 43 operated fractures). The fractures are classified in 4 groups (A. transverse fractures, B. oblique fractures, C. comminuted fractures and D. fractures associated with other injuries in the elbow joint). Each of these groups is devided into 3 types according to the displacement of the fragments. Good results by conservative treatment were always seen in fractures with separation of the fragments less than 2 mm. A relative indication for surgical treatment is displacement from 2 up to 10 mm. Only surgical treatment can prevent non-union in fractures with separation of the fragments more than 10 mm. A new sheme for classification of the results is proposed, and late results of the followed up cases are reported. Immobilization of the elbow in full extension is rejected in the conservative treatment. The internal fixation of prestress type by the Weber technique and the osteosynthesis with Spongiosa-screw are the preponderant methods actually used in surgical treatment.


Assuntos
Fraturas da Ulna/cirurgia , Fraturas da Ulna/terapia , Adolescente , Adulto , Fatores Etários , Idoso , Criança , Pré-Escolar , Feminino , Seguimentos , Fixação Interna de Fraturas/métodos , Humanos , Masculino , Pessoa de Meia-Idade , Radiografia , Fraturas da Ulna/classificação , Fraturas da Ulna/diagnóstico por imagem , Lesões no Cotovelo
18.
Dtsch Med Wochenschr ; 127(28-29): 1516-20, 2002 Jul 12.
Artigo em Alemão | MEDLINE | ID: mdl-12111657

RESUMO

HISTORY AND ADMISSION FINDINGS: A 57-year-old depressive and alcohol-dependent man was admitted because of frequent nausea and vomiting and abdominal complaints after he had ingested 40 ml of a tincture for treating warts. He was under the influence of alcohol, but normally oriented and without contributory findings other than his gastrointestinal complaints and tachypnea. INVESTIGATIONS: Transaminases were raised (GOT 1197 U/l, GPT 170 U/l, gammaGT 150 U/l, LDH 2047 U/l), as were creatine phosphokinase (426 U/l) and ferritin (12 200 ng/ml). Platelet count was 36000 mm3, Leucocytes count 11 700/mm (3). Gastroscopy showed marked mucosal necrosis along the entire esophagus and the pulled-up small intestine (state after gastrectomy). DIAGNOSIS, TREATMENT AND COURSE: The patient became comatose within 5 hours, acidotic, oliguric, required ventilation and went into severe shock. The symptoms and the fact that podophyllin (pod.) was the main agent in the wart preparation confirmed the suspicion of pod. poisoning. Symptomatic and intensive care measures stabilized his critically grave condition. He was extubated on the 7th day after ingestion and on the 10th day was discharged at his own request in a relatively good general state. When he was re-admitted after 4 weeks he was without psychiatric symptoms but deeply depressed, and he had signs of a polyneuropathy in all limbs, typical of pod. toxin poisoning. CONCLUSION: Pod. toxin, a spindle poison, is the toxic agent of pod., the resin from the roots and rhizomes of various Berberis plants. While the potential toxicity of the resin, taken either orally or applied externally, has been long known, the poorly definied raw product is still being added to anti-wart tinctures.


Assuntos
Ceratolíticos/intoxicação , Podofilotoxina/intoxicação , Polineuropatias/induzido quimicamente , Administração Oral , Alcoolismo , Coma/induzido quimicamente , Depressão/induzido quimicamente , Esôfago/lesões , Esôfago/patologia , Hospitalização , Humanos , Ceratolíticos/química , Ceratolíticos/uso terapêutico , Masculino , Pessoa de Meia-Idade , Contagem de Plaquetas , Podofilina/química , Podofilina/intoxicação , Podofilina/uso terapêutico , Verrugas/tratamento farmacológico
19.
Chir Forum Exp Klin Forsch ; (1978): 239-42, 1978.
Artigo em Alemão | MEDLINE | ID: mdl-752592

RESUMO

The influence of taurocholate-induced damage of the gastric mucosal barrier on transmucosal movement of methyl-N-nitro-N-nitrosoguanidine (MNNG) was investigated on dogs with Heidenhain pouches. We also investigated whether or not MNNG influences the mucosal barrier. The results of 10 experiments revealed no effect of MNNG on the mucosal barrier, but a significant time-related decrease of intraluminal MNNG concentration in the presence of taurocholate.


Assuntos
Mucosa Gástrica/efeitos dos fármacos , Metilnitronitrosoguanidina/metabolismo , Ácido Taurocólico/farmacologia , Animais , Permeabilidade da Membrana Celular/efeitos dos fármacos , Cães , Mucosa Gástrica/metabolismo , Concentração Osmolar , Fatores de Tempo
20.
Zentralbl Chir ; 101(23): 1420-6, 1976.
Artigo em Alemão | MEDLINE | ID: mdl-65067

RESUMO

UNLABELLED: 181 patients with mechanical bowel obstruction were treated between 1965 and 1974 at the First Surgical Clinic of the University of Vienna. 172 were operated, 7 had conservative treatment. RESULTS: 1. the mortality was 24,3% and infavorably influenced by a) advanced malignant tumors, b) age over 60 years, c) preexistent peritonitis. -2. Enterotomy for bowel-decompression was in no case followed by a complication.- 3. Nobles operation should be performed only totally and in cases of severe adhaesions. 4. Discussion of the one stage operation in large bowel obstruction, which is only indicated in patients with good general condition. The high letality of 47% after operations in cases with ileus due to carcinosis peritonei requires critical indications for these operations.


Assuntos
Obstrução Intestinal/cirurgia , Idoso , Criança , Colostomia , Humanos , Obstrução Intestinal/etiologia , Pessoa de Meia-Idade , Cuidados Paliativos , Neoplasias Peritoneais/complicações , Neoplasias Peritoneais/cirurgia , Peritonite/etiologia , Complicações Pós-Operatórias
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA